NLRP3 and chronic obstructive pulmonary disease: Another study demonstrated that P22077 may inhibit the formation of NLRP3 inflammatory vesicle complexes and affect the activation of the inflammatory vesicle pathway in COPD rats, thereby reducing the release of downstream inflammatory mediators and ultimately controlling the progression of COPD [20].